FDA Approves Eli Lilly's Zepbound for Obstructive Sleep Apnea
Eli Lilly's Zepbound receives FDA approval for treating obstructive sleep apnea in obese adults, marking a significant advancement in pharmaceutical care.
Eli Lilly's Zepbound received FDA approval as a treatment for obstructive sleep apnea in adults with obesity.